Have guidelines been oblivious to the obvious? Unmasking the positives from the COVID-19 pandemic.
作者信息
Vishak Acharya K, Unnikrishnan B, Sindhu K, Deepthi S
机构信息
Department of Pulmonary Medicine, Kasturba Medical College, Mangalore, MAHE, Manipal, India.
Department of Preventive & Community Medicine, Kasturba Medical College, Mangalore, MAHE, Manipal, India.
出版信息
NPJ Prim Care Respir Med. 2021 Feb 26;31(1):11. doi: 10.1038/s41533-021-00224-0.
Abstract
摘要
相似文献
1
Have guidelines been oblivious to the obvious? Unmasking the positives from the COVID-19 pandemic.指南是否忽略了显而易见的事情？揭示新冠疫情中的积极方面。
NPJ Prim Care Respir Med. 2021 Feb 26;31(1):11. doi: 10.1038/s41533-021-00224-0.
2
Low prevalence of asthma in Mexican children and adults with a positive rtRT-PCR test for SARS-CoV-2: a cross-sectional study during the 2020 pandemic.2020年疫情期间一项横断面研究：SARS-CoV-2逆转录实时聚合酶链反应（rtRT-PCR）检测呈阳性的墨西哥儿童和成人中哮喘的低患病率
Allergol Immunopathol (Madr). 2021 May 1;49(3):1-7. doi: 10.15586/aei.v49i3.7. eCollection 2021.
3
Asthma and COPD in Hospitalized COVID-19 Patients.住院COVID-19患者中的哮喘和慢性阻塞性肺疾病
Arch Bronconeumol (Engl Ed). 2020 Sep;56(9):604-606. doi: 10.1016/j.arbres.2020.05.007. Epub 2020 May 31.
4
Co-morbid conditions in COVID-19 patients in Uttarakhand state of India.印度北阿坎德邦新冠肺炎患者的合并症。
J Glob Health. 2021 Feb 15;11:03029. doi: 10.7189/jogh.11.03029.
5
Caring for patients with COPD and COVID-19: a viewpoint to spark discussion.关爱慢性阻塞性肺疾病（COPD）合并新型冠状病毒肺炎（COVID-19）患者：引发讨论的观点
Thorax. 2020 Dec;75(12):1035-1039. doi: 10.1136/thoraxjnl-2020-215095. Epub 2020 Sep 2.
6
Focusing on Asthma and Chronic Obstructive Pulmonary Disease with COVID-19.聚焦 COVID-19 下的哮喘和慢性阻塞性肺疾病。
J Infect Dev Ctries. 2021 Oct 31;15(10):1415-1425. doi: 10.3855/jidc.14611.
7
Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID-19.新型冠状病毒肺炎重症监护病房患者中支气管哮喘和慢性阻塞性肺疾病的低患病率
Allergy. 2020 Oct;75(10):2703-2704. doi: 10.1111/all.14420. Epub 2020 Jun 12.
8
Association of asthma and its genetic predisposition with the risk of severe COVID-19.哮喘及其遗传易感性与重症 COVID-19 风险的关联。
J Allergy Clin Immunol. 2020 Aug;146(2):327-329.e4. doi: 10.1016/j.jaci.2020.06.001. Epub 2020 Jun 6.
9
[COVID-19 and asthma control].[新型冠状病毒肺炎与哮喘控制]
Rev Mal Respir. 2021 Jan;38(1):111-113. doi: 10.1016/j.rmr.2020.11.006. Epub 2020 Nov 17.
10
Hospitalizations for Chronic Obstructive Pulmonary Disease Exacerbation During COVID-19.新冠疫情期间慢性阻塞性肺疾病急性加重的住院情况
JAMA Netw Open. 2024 May 1;7(5):e2412383. doi: 10.1001/jamanetworkopen.2024.12383.
引用本文的文献
1
Impact of COVID-19 Pandemic on the Exacerbation Rates in COPD Patients in Southern India - A Potential Role for Community Mitigations Measures.新冠疫情对印度南部 COPD 患者恶化率的影响-社区缓解措施的潜在作用。
Int J Chron Obstruct Pulmon Dis. 2023 Aug 29;18:1909-1917. doi: 10.2147/COPD.S412268. eCollection 2023.
本文引用的文献
1
Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis.物理隔离、口罩和眼部防护预防 SARS-CoV-2 和 COVID-19 的人际传播：系统评价和荟萃分析。
Lancet. 2020 Jun 27;395(10242):1973-1987. doi: 10.1016/S0140-6736(20)31142-9. Epub 2020 Jun 1.
2
Clinical Characteristics of Covid-19 in New York City.纽约市新冠肺炎的临床特征
N Engl J Med. 2020 Jun 11;382(24):2372-2374. doi: 10.1056/NEJMc2010419. Epub 2020 Apr 17.
3
Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?慢性呼吸道疾病或其治疗是否会影响感染SARS-CoV-2的风险？
Lancet Respir Med. 2020 May;8(5):436-438. doi: 10.1016/S2213-2600(20)30167-3. Epub 2020 Apr 3.
4
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
5
Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis.新冠病毒肺炎住院患者基础疾病的患病率：一项系统评价与Meta分析
Arch Acad Emerg Med. 2020 Mar 24;8(1):e35. eCollection 2020.
6
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.中国 COVID-19 患者 1590 例的合并症及其影响：一项全国性分析。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00547-2020. Print 2020 May.
7
GARD, a new way to battle with chronic respiratory diseases, from disease oriented programmes to global partnership.全球哮喘防治创议（GARD），一种与慢性呼吸道疾病作斗争的新方法，从以疾病为导向的项目到全球伙伴关系。
J Thorac Dis. 2017 Nov;9(11):4676-4689. doi: 10.21037/jtd.2017.11.91.
Zotero 插件